Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy
NCT06453213Phase 4Active, not recruiting
- Sponsor
- SK Life Science, Inc.
- Start
- Oct 2024
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cenobamate in focal epilepsy, sponsored by SK Life Science, Inc.. Started Oct 2024; status: active, not recruiting.
02
Drugs
cenobamate
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT06453213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06453213.